DNTH
NASDAQ · Biotechnology
Dianthus Therapeutics Inc
$85.47
-4.95 (-5.47%)
Performance
1D
—
1W
—
1M
—
3M
+62.15%
6M
+136.76%
1Y
+325.65%
YTD
+115.40%
Open$91.24
Previous Close$90.42
Day High$91.24
Day Low$83.56
52W High$96.50
52W Low$16.64
Volume—
Avg Volume505.1K
Market Cap4.74B
P/E Ratio—
EPS$-4.11
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$45.37
Above
SMA 200
$31.95
Above
RSI (14)
42.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
-54.6% upside
Current
$85.47
$85.47
Target
$38.82
$38.82
$27.89
$38.82 avg
$53.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.92M | 305.72M | 270.76M |
| Net Income | -233,134,408 | -32,339,215 | -26,813,974 |
| Profit Margin | -7,973.3% | -10.6% | -9.9% |
| EBITDA | -256,771,177 | -32,605,970 | -27,281,394 |
| Free Cash Flow | — | -20,890,110 | -21,520,158 |
| Rev Growth | — | +9.7% | -3.3% |
| Debt/Equity | — | 0.57 | 0.83 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |